Clinical presentation and management of intrahepatic cholangiocarcinoma;Présentation clinique et prise en charge des cholangiocarcinomes intrahépatiques

Gastroenterologie Clinique et Biologique

Volumn 34, Issue 3, 2010, Pages 191-199

  Farges, O ^a   Fuks, D ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CETUXIMAB; ERLOTINIB; GEFITINIB; LAPATINIB; SORAFENIB; TRASTUZUMAB;

AGE; BILE DUCT CARCINOMA; BILE DUCT MALFORMATION; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHEMOEMBOLIZATION; CHOLELITHIASIS; COLON CANCER; COLONOSCOPY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE SURVEILLANCE; GENDER; GENETIC HETEROGENEITY; GEOGRAPHIC DISTRIBUTION; HUMAN; LIVER FAILURE; LIVER TRANSPLANTATION; PRIMARY SCLEROSING CHOLANGITIS; RADIOFREQUENCY ABLATION; SENSITIVITY AND SPECIFICITY; SEPSIS; SHORT SURVEY;

EID: 77951022509     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gcb.2010.01.006     Document Type: Short Survey

References (38)

1. Available at: http://seer.cancer.gov/publications/survival/seer_survival_mono_highres. pdf.
2. Ikai I., Arii S., Okazaki M., Okita K., Omata M., Kojiro M., et al. Report of the 17th Nationwide Follow-up Survey of Primary Liver Cancer in Japan. Hepatol Res 2007, 37:676-691.
3. e Congrès français de chirurgie 2009, Arnette Wolker Kluver, France. J.M. Regimbeau, F.R. Pruvot, O. Farges (Eds).
4. DeOliveira M.L., Cunningham S.C., Cameron J.L., Kamangar F., Winter J.M., Lillemoe K.D., et al. Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg 2007, 245(5):755-762.
5. IARC. Cancer incidence in five continents, vol IX. Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, et al. (eds). IARC scinetific publications no. 160, Lyon, IARC, 2007.
6. Borie F., Trétarre B., Bouvier A.M., Faivre J., Binder F., Launois G., et al. Primitive liver cancers: epidemiology and geographical study in France. Eur J Gastroenterol Hepatol 2009, 21:984-989.
7. Availalbe at: http://seer.cancer.gov/csr/1975_2004/resuts_merged/topic_histologic_tabs .pdf.
8. Borie F., Niampa H., Bouvier A.M., Faivre J., Launoy G., Delafosse P., et al. Current management and prognosis of intrahepatic cholangiocarcinoma in France. Gastroenterol Clin Biol 2009, 33:971-976.
9. Borie F., Bouvier A.M., Herrero A., Faivre J., Launoy G., Delafosse P., et al. Treatment and prognosis of hepatocellular carcinoma: a population based study in France. J Surg Oncol 2008, 98:505-509.
10. Lang H., Sotiropoulos G.C., Sgourakis G., Schmitz K.J., Paul A., Hilgard P., et al. Operations for intrahepatic cholangiocarcinoma: single-institution experience of 158 patients. J Am Coll Surg 2009, 208:218-228.
11. Paik K.Y., Jung J.C., Heo J.S., Choi S.H., Choi D.W., Kim Y.I. What prognostic factors are important for resected intrahepatic cholangiocarcinoma?. J Gastroenterol Hepatol 2008, 23:766-770.
12. Endo I., Gonen M., Yopp A.C., Dalal K.M., Zhou Q., Klimstra D., et al. Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection. Ann Surg 2008, 248:84-96.
13. Tamandl D., Herberger B., Gruenberger B., Puhalla H., Klinger M., Gruenberger T. Influence of hepatic resection margin on recurrence and survival in intrahepatic cholangiocarcinoma. Ann Surg Oncol 2008, 15:2787-2794.
14. Yedibela S., Demir R., Zhang W., Meyer T., Hohenberger W., Schönleben F. Surgical treatment of mass-forming intrahe-patic cholangiocarcinoma: an 11-year Western single-center experience in 107 patients. Ann Surg Oncol 2009, 16:404-412.
15. Shimada K., Sano T., Sakamoto Y., Esaki M., Kosuge T., Ojima H. Surgical outcomes of the mass-forming plus periductal infiltrating types of intrahepatic cholangiocarcinoma: a comparative study with the typical mass-forming type of intrahepatic cholangiocarcinoma. World J Surg 2007, 31:2016-2022.
16. Cho Y.K., Chung J.W., Kim J.K., Ahn Y.S., Kim M.Y., Park Y.O., et al. Comparison of 7 staging systems for patients with hepatocellular carcinoma undergoing transarterial chemoembolization. Cancer 2008, 15(112):352-361.
17. Minagawa M., Ikai I., Matsuyama Y., Yamaoka Y., Makuuchi M. Staging of hepatocellular carcinoma: assessment of the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13,772 patients in Japan. Ann Surg 2007, 245:909-922.
18. Nathan H., Aloia T.A., Vauthey J.N., Abdalla E.K., Zhu A.X., Schulick R.D., et al. A proposed staging system for intrahepatic cholangiocarcinoma. Ann Surg Oncol 2009, 16:14-22.
19. Sano T., Shimada K., Sakamoto Y., Ojima H., Esaki M., Kosuge T. Prognosis of perihilar cholangiocarcinoma: hilar bile duct cancer versus intrahepatic cholangiocarcinoma involving the hepatic hilus. Ann Surg Oncol 2008, 15:590-599.
20. Jonas S., Thelen A., Benckert C., Biskup W., Neumann U., Rudolph B., et al. Extended liver resection for intrahepatic cholangiocarcinoma: A comparison of the prognostic accuracy of the fifth and sixth editions of the TNM classification. Ann Surg 2009, 249:303-309.
21. Okabayashi T., Yamamoto J., Kosuge T., Shimada K., Yamasaki S., Takayama T., et al. A new staging system for mass-forming intrahepatic cholangiocarcinoma: analysis of preoperative and postoperative variables. Cancer 2001, 92:2374-2383.
22. Ercolani G., Grazi G.L., Ravaioli M., Grigioni W.F., Cescon M., Gardini A., et al. The role of lymphadenectomy for liver tumors: further considerations on the appropriateness of treatment strategy. Ann Surg 2004, 239:202-209.
23. Noji T., Kondo S., Hirano S., Tanaka E., Suzuki O., Shichinohe T. Computed tomography evaluation of regional lymph node metastases in patients with biliary cancer. Br J Surg 2008, 95(1):92-96.
24. Yamasaki S. Intrahepatic cholangiocarcinoma: macroscopic type and stage classification. J Hepatobiliary Pancreat Surg 2003, 10:288-291.
25. Song G.W., Lee S.G., Lee Y.J., Park K.M., Hwang S., Kim K.H., et al. Analysis of survival and factors affecting the survival after surgical resection of peripheral cholangiocarcinoma: 318 cases in single institute. Korean J Hepatol 2007, 13:208-221.
26. Weimann A., Varnholt H., Schlitt H.J., Lang H., Flemming P., Hustedt C., et al. Retrospective analysis of prognostic factors after liver resection and transplantation for cholangiocellular carcinoma. Br J Surg 2000, 87:1182-1187.
27. Yamamoto M., Takasaki K., Otsubo T., Katsuragawa H., Katagiri S. Recurrence after surgical resection of intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg 2001, 8:154-157.
28. Kim J.H., Yoon H.K., Sung K.B., Ko G.Y., Gwon D.I., Shin J.H., et al. Transcatheter arterial chemoembolization or chemoinfusion for unresectable intrahepatic cholangiocarcinoma: clinical efficacy and factors influencing outcomes. Cancer 2008, 113:1614-1622.
29. Aliberti C., Benea G., Tilli M., Fiorentini G. Chemoembolization (TACE) of unresectable intrahepatic cholangiocarcinoma with slow-release doxorubicin-eluting beads: preliminary results. Cardiovasc Intervent Radiol 2008, 31:883-888.
30. Ibrahim S.M., Mulcahy M.F., Lewandowski R.J., Sato K.T., Ryu R.K., Masterson E.J., et al. Treatment of unresectable cholangiocarcinoma using yttrium-90 microspheres: results from a pilot study. Cancer 2008, 113:2119-2128.
31. Pruvot RF, Boleslawski E, Chevallier C. Transplantation hépatique pour cholangiocarcinome. In: Chirurgie des cholangiocarcinomes intrahépatiques, hilaires et vésiculaires. Rapport présenté au 111e Congrès français de chirurgie. Regimbeau JM, Pruvot FR, Farges O Eds. Arnette Wolker Kluver, France, 2009.
32. Heimbach J.K., Gores G.J., Nagorney D.M., Rosen C.B. Liver transplantation for perihilar cholangiocarcinoma after aggressive neoadjuvant therapy: a new paradigm for liver and biliary malignancies?. Surgery 2006, 140:331-334.
33. Available at http://www.snfge.asso.fr/01-Bibliotheque/OG-Thesaurus-Cancerologie.
34. Guedj N., Zhan Q., Perigny M., Rautou P.E., Degos F., Belghiti J., et al. Comparative protein expression profiles of hilar and peripheral hepatic cholangiocarcinomas. J Hepatol 2009, 51:93-101.
35. Adam R., Aloia T., Figueras J., Capussotti L., Poston G., Mentha G., et al. LiverMetSurvey: analysis of clinicopathologic factors associated with the efficacy of preoperative chemotherapy in 2,122 patients with colorectal liver metastases. J Clin Oncol 2006, 24:3521. [ASCO Annual Meeting Proceedings Part I].
36. Fan S.T., Lo C.M., Liu C.L., Lam C.M., Yuen W.K., Yeung C., et al. Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths. Ann Surg 1999, 229:322-330.
37. Shaib Y.H., Davila J.A., McGlynn K., El-Serag H.B. Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?. J Hepatol 2004, 40:472-477.
38. Tan J.C., Coburn N.G., Baxter N.N., Kiss A., Law C.H. Surgical management of intrahepatic cholangiocarcinoma: a population-based study. Ann Surg Oncol 2008, 15:600-608.